Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Seroquel SR NDA Submitted For Schizophrenia

Jul 18 2006

• By Jessica Merrill

Related Content

Seroquel Sustained-Release Could Avert Sunset On Patent Exclusivity, AstraZeneca Says

Jun 08 2006

AstraZeneca Submits Seroquel sNDA For Bipolar Depression Indication

Dec 30 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window